vs
Palomar Holdings, Inc.（PLMR）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Palomar Holdings, Inc.的季度营收约是REPLIGEN CORP的1.3倍（$253.4M vs $197.9M），Palomar Holdings, Inc.同比增速更快（62.7% vs 13.6%），Palomar Holdings, Inc.自由现金流更多（$409.0M vs $17.6M），过去两年Palomar Holdings, Inc.的营收复合增速更高（46.2% vs 14.4%）
Palomar Holdings, Inc.是一家专业保险控股企业，主要为存在巨灾风险敞口的住宅及商业资产提供财产保险产品，业务范围覆盖美国全境，核心业务板块包含地震、洪水、风暴等高危财产保障服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PLMR vs RGEN — 直观对比
营收规模更大
PLMR
是对方的1.3倍
$197.9M
营收增速更快
PLMR
高出49.0%
13.6%
自由现金流更多
PLMR
多$391.4M
$17.6M
两年增速更快
PLMR
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $253.4M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 28.7% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 62.7% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $2.05 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLMRRGEN
| Q4 25 | $253.4M | $197.9M | ||
| Q3 25 | $244.7M | $188.8M | ||
| Q2 25 | $203.3M | $182.4M | ||
| Q1 25 | $174.6M | $169.2M | ||
| Q4 24 | $155.8M | $174.1M | ||
| Q3 24 | $148.5M | $154.9M | ||
| Q2 24 | $131.1M | $154.1M | ||
| Q1 24 | $118.5M | $151.3M |
净利润PLMRRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $51.5M | $14.9M | ||
| Q2 25 | $46.5M | $14.9M | ||
| Q1 25 | $42.9M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $30.5M | $-654.0K | ||
| Q2 24 | $25.7M | $3.3M | ||
| Q1 24 | $26.4M | $2.1M |
毛利率PLMRRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率PLMRRGEN
| Q4 25 | 28.7% | 9.0% | ||
| Q3 25 | 27.4% | 8.9% | ||
| Q2 25 | 29.5% | 7.6% | ||
| Q1 25 | 30.8% | 3.9% | ||
| Q4 24 | 28.9% | -17.7% | ||
| Q3 24 | 25.9% | -5.1% | ||
| Q2 24 | 25.5% | 1.0% | ||
| Q1 24 | 29.0% | 1.3% |
净利率PLMRRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 21.0% | 7.9% | ||
| Q2 25 | 22.9% | 8.2% | ||
| Q1 25 | 24.6% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 20.5% | -0.4% | ||
| Q2 24 | 19.6% | 2.2% | ||
| Q1 24 | 22.3% | 1.4% |
每股收益（稀释后）PLMRRGEN
| Q4 25 | $2.05 | $0.24 | ||
| Q3 25 | $1.87 | $0.26 | ||
| Q2 25 | $1.68 | $0.26 | ||
| Q1 25 | $1.57 | $0.10 | ||
| Q4 24 | $1.29 | $-0.55 | ||
| Q3 24 | $1.15 | $-0.01 | ||
| Q2 24 | $1.00 | $0.06 | ||
| Q1 24 | $1.04 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $106.9M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $942.7M | $2.1B |
| 总资产 | $3.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PLMRRGEN
| Q4 25 | $106.9M | $767.6M | ||
| Q3 25 | $111.7M | $748.7M | ||
| Q2 25 | $81.3M | $708.9M | ||
| Q1 25 | $119.3M | $697.2M | ||
| Q4 24 | $80.4M | $757.4M | ||
| Q3 24 | $86.5M | $784.0M | ||
| Q2 24 | $47.8M | $809.1M | ||
| Q1 24 | $61.4M | $780.6M |
总债务PLMRRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PLMRRGEN
| Q4 25 | $942.7M | $2.1B | ||
| Q3 25 | $878.1M | $2.1B | ||
| Q2 25 | $847.2M | $2.1B | ||
| Q1 25 | $790.4M | $2.0B | ||
| Q4 24 | $729.0M | $2.0B | ||
| Q3 24 | $703.3M | $2.0B | ||
| Q2 24 | $532.6M | $2.0B | ||
| Q1 24 | $501.7M | $2.0B |
总资产PLMRRGEN
| Q4 25 | $3.1B | $2.9B | ||
| Q3 25 | $2.9B | $2.9B | ||
| Q2 25 | $2.8B | $2.9B | ||
| Q1 25 | $2.4B | $2.9B | ||
| Q4 24 | $2.3B | $2.8B | ||
| Q3 24 | $2.3B | $2.8B | ||
| Q2 24 | $2.0B | $2.9B | ||
| Q1 24 | $1.9B | $2.8B |
负债/权益比PLMRRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $409.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $409.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 161.4% | 8.9% |
| 资本支出强度资本支出/营收 | 0.1% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $700.6M | $93.9M |
8季度趋势，按日历期对齐
经营现金流PLMRRGEN
| Q4 25 | $409.1M | $25.7M | ||
| Q3 25 | $83.6M | $48.1M | ||
| Q2 25 | $120.9M | $28.6M | ||
| Q1 25 | $87.2M | $15.0M | ||
| Q4 24 | $261.2M | $39.2M | ||
| Q3 24 | $100.3M | $49.3M | ||
| Q2 24 | $55.1M | $42.2M | ||
| Q1 24 | $33.1M | $44.7M |
自由现金流PLMRRGEN
| Q4 25 | $409.0M | $17.6M | ||
| Q3 25 | $83.6M | $43.4M | ||
| Q2 25 | $120.8M | $21.5M | ||
| Q1 25 | $87.1M | $11.4M | ||
| Q4 24 | $260.9M | $33.6M | ||
| Q3 24 | $100.1M | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率PLMRRGEN
| Q4 25 | 161.4% | 8.9% | ||
| Q3 25 | 34.2% | 23.0% | ||
| Q2 25 | 59.4% | 11.8% | ||
| Q1 25 | 49.9% | 6.8% | ||
| Q4 24 | 167.5% | 19.3% | ||
| Q3 24 | 67.4% | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度PLMRRGEN
| Q4 25 | 0.1% | 4.1% | ||
| Q3 25 | 0.0% | 2.5% | ||
| Q2 25 | 0.0% | 3.9% | ||
| Q1 25 | 0.0% | 2.1% | ||
| Q4 24 | 0.2% | 3.2% | ||
| Q3 24 | 0.1% | 4.5% | ||
| Q2 24 | 0.0% | 3.1% | ||
| Q1 24 | 0.0% | 5.5% |
现金转化率PLMRRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 1.63× | 3.23× | ||
| Q2 25 | 2.60× | 1.92× | ||
| Q1 25 | 2.03× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.29× | — | ||
| Q2 24 | 2.14× | 12.70× | ||
| Q1 24 | 1.26× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
